Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
American tourists left stranded in the Caribbean following flight cancellations after airspace closed for Maduro operation - 2Fundamental Home Exercise center Hardware: Amplify Your Exercises
- 3UK can legally stop shadow fleet tankers, ministers believe
- 4Surveys of 6 Hot Savvy Beds
- 5What's an atmospheric river? AP explains the weather phenomenon
- Find the Mysteries of Powerful Using time productively: Augmenting Efficiency and Proficiency
- Share your pick for the riding area that characterizes your surf undertakings!
- Planet-eating stars hint at Earth's ultimate fate
- Astronomer captures 2 meteors slamming into the moon (video)
- Instructions to Perform Fundamental Upkeep on Your Slam 1500.
- the Kinds of Thailand: Decision in favor of Your Number one Thai Dish!
- Dominating Monetary Administration: A Bit by bit Manual for Making an Individual Financial plan
- Tributes pour in for James Ransone, 'The Wire' actor who died at 46
- 'The best gift ever': Baby is born after the rarest of pregnancies, defying all odds
